Prof. Dr. Ali Canbay

Pic of Prof. Dr. Ali Canbay

Clinic Director – Department of Medicine – University Hospital Knappschaftskrankenhaus Bochum

Role in LiSyM-Cancer

  • Project leader in C-TIP-HCC
  • Contributes serum/plasma from patients with cirrhosis with or without HCC and liver/tumor tissue from patients undergoing liver resection/transplantation; liver tissue from partial liver resections for cell isolation


  • Clinical, translational and basic research in hepatology and gastroenterology with a particular focus on non-alcoholic fatty liver disease, acute liver failure, hepatocellular carcinoma and cholangiocarcinoma
  • Contributor to the GALAD model for indication of hepatocarcinogenesis prior to first HCC diagnosis


  • Since 2010, associate professor
  • 2001 - 2003, DAAD scholarship holder and doctorate in the Department of Gastroenterology and Hepatology at the Mayo Clinic in Rochester (USA)
  • Until 1997, Studies of human medicine, Ruhr University in Bochum

Professional Experience

  • Since 2019, Director of the Department of Medicine, Universitätsklinikum Knappschaftskrankenhaus Knappschaftskrankenhaus Bochum, Ruhr-University Bochum
  • 2018, Additional qualifications in "Transplantation Medicine" and "Drug-based Tumour Therapy"
  • 2017, Appointment as Professor of Gastroenterology, Hepatology and Infectiology at the Otto-von-Guericke University Magdeburg.
  • 2012, Medical Director of the Intermediate Care Unit (IMC) at the University Hospital Essen
  • 2007 - 2010, senior physician, Clinic for Gastroenterology and Hepatology, University Hospital Essen, additional qualifications in "Internal Intensive Care Medicine" (2008) and "Gastroenterology" (2010)
  • Until 2006 specialist training, Centre for Internal Medicine at Essen University Hospital

Honors and Awards (selection)

  • 2024, President of the Visceral Medicine Congress North-Rhine Westphalia
  • 2023, Visiting Professorship at the Saint Louis University (MO, USA)
  • 2022 - 2023, President of the German Association for the Study of the Liver (GASL)
  • 2014, Visiting Professor Ulaanbaatar (Mongolia)
  • 2012, Visiting Professorship at the University of California, San Diego (USA)
  • 2012, "Hiromasa Ishi Memorial Award" of International Society for Biomedical Research on Alcoholism (Japan)
  • 2004, "Edward-Kendall-Award" for best young academic, Mayo-Klinik in Rochester (USA)
  • Member guideline commission „Lebertransplantation“ (DGVS)
  • Panel member of the European guideline commission for “EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease”
  • Coordinator for the S2k guideline „Nicht-alkoholische Fettlebererkrankung“ (DGVS)